1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Companion Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Companion Diagnostics Market, by Indication
8.1.1. Cancer
8.1.1.1. Market Revenue and Forecast
8.1.2. Neurological Disorders
8.1.2.1. Market Revenue and Forecast
8.1.3. Cardiovascular Diseases
8.1.3.1. Market Revenue and Forecast
8.1.4. Infectious Diseases
8.1.4.1. Market Revenue and Forecast
8.1.5. Other Indications
8.1.5.1. Market Revenue and Forecast
9.1. Companion Diagnostics Market, by Product & Service
9.1.1. Assays, Kits & Reagents
9.1.1.1. Market Revenue and Forecast
9.1.2. Software & Services
9.1.2.1. Market Revenue and Forecast
10.1. Companion Diagnostics Market, by Technology
10.1.1. Polymerase Chain Reaction
10.1.1.1. Market Revenue and Forecast
10.1.2. Next-generation Sequencing
10.1.2.1. Market Revenue and Forecast
10.1.3. In Situ Hybridization
10.1.3.1. Market Revenue and Forecast
10.1.4. Immunohistochemistry
10.1.4.1. Market Revenue and Forecast
10.1.5. Other
10.1.5.1. Market Revenue and Forecast
11.1. Companion Diagnostics Market, by Indication
11.1.1. Oncology
11.1.1.1. Market Revenue and Forecast
11.1.2. Neurology
11.1.2.1. Market Revenue and Forecast
11.1.3. Infectious Diseases
11.1.3.1. Market Revenue and Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Forecast
12.1. Companion Diagnostics Market, by End-User
12.1.1. Pharmaceutical & Biopharmaceutical Companies
12.1.1.1. Market Revenue and Forecast
12.1.2. Reference Laboratories
12.1.2.1. Market Revenue and Forecast
12.1.3. Contract Research Organizations
12.1.3.1. Market Revenue and Forecast
12.1.4. Other End Users
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Indication
13.1.2. Market Revenue and Forecast, by Product & Service
13.1.3. Market Revenue and Forecast, by Technology
13.1.4. Market Revenue and Forecast, by Indication
13.1.5. Market Revenue and Forecast, by End-User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Indication
13.1.6.2. Market Revenue and Forecast, by Product & Service
13.1.6.3. Market Revenue and Forecast, by Technology
13.1.6.4. Market Revenue and Forecast, by Indication
13.1.6.5. Market Revenue and Forecast, by End-User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Indication
13.1.7.2. Market Revenue and Forecast, by Product & Service
13.1.7.3. Market Revenue and Forecast, by Technology
13.1.7.4. Market Revenue and Forecast, by Indication
13.1.7.5. Market Revenue and Forecast, by End-User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Indication
13.2.2. Market Revenue and Forecast, by Product & Service
13.2.3. Market Revenue and Forecast, by Technology
13.2.4. Market Revenue and Forecast, by Indication
13.2.5. Market Revenue and Forecast, by End-User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Indication
13.2.6.2. Market Revenue and Forecast, by Product & Service
13.2.6.3. Market Revenue and Forecast, by Technology
13.2.7. Market Revenue and Forecast, by Indication
13.2.8. Market Revenue and Forecast, by End-User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Indication
13.2.9.2. Market Revenue and Forecast, by Product & Service
13.2.9.3. Market Revenue and Forecast, by Technology
13.2.10. Market Revenue and Forecast, by Indication
13.2.11. Market Revenue and Forecast, by End-User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Indication
13.2.12.2. Market Revenue and Forecast, by Product & Service
13.2.12.3. Market Revenue and Forecast, by Technology
13.2.12.4. Market Revenue and Forecast, by Indication
13.2.13. Market Revenue and Forecast, by End-User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Indication
13.2.14.2. Market Revenue and Forecast, by Product & Service
13.2.14.3. Market Revenue and Forecast, by Technology
13.2.14.4. Market Revenue and Forecast, by Indication
13.2.15. Market Revenue and Forecast, by End-User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Indication
13.3.2. Market Revenue and Forecast, by Product & Service
13.3.3. Market Revenue and Forecast, by Technology
13.3.4. Market Revenue and Forecast, by Indication
13.3.5. Market Revenue and Forecast, by End-User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Indication
13.3.6.2. Market Revenue and Forecast, by Product & Service
13.3.6.3. Market Revenue and Forecast, by Technology
13.3.6.4. Market Revenue and Forecast, by Indication
13.3.7. Market Revenue and Forecast, by End-User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Indication
13.3.8.2. Market Revenue and Forecast, by Product & Service
13.3.8.3. Market Revenue and Forecast, by Technology
13.3.8.4. Market Revenue and Forecast, by Indication
13.3.9. Market Revenue and Forecast, by End-User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Indication
13.3.10.2. Market Revenue and Forecast, by Product & Service
13.3.10.3. Market Revenue and Forecast, by Technology
13.3.10.4. Market Revenue and Forecast, by Indication
13.3.10.5. Market Revenue and Forecast, by End-User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Indication
13.3.11.2. Market Revenue and Forecast, by Product & Service
13.3.11.3. Market Revenue and Forecast, by Technology
13.3.11.4. Market Revenue and Forecast, by Indication
13.3.11.5. Market Revenue and Forecast, by End-User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Indication
13.4.2. Market Revenue and Forecast, by Product & Service
13.4.3. Market Revenue and Forecast, by Technology
13.4.4. Market Revenue and Forecast, by Indication
13.4.5. Market Revenue and Forecast, by End-User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Indication
13.4.6.2. Market Revenue and Forecast, by Product & Service
13.4.6.3. Market Revenue and Forecast, by Technology
13.4.6.4. Market Revenue and Forecast, by Indication
13.4.7. Market Revenue and Forecast, by End-User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Indication
13.4.8.2. Market Revenue and Forecast, by Product & Service
13.4.8.3. Market Revenue and Forecast, by Technology
13.4.8.4. Market Revenue and Forecast, by Indication
13.4.9. Market Revenue and Forecast, by End-User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Indication
13.4.10.2. Market Revenue and Forecast, by Product & Service
13.4.10.3. Market Revenue and Forecast, by Technology
13.4.10.4. Market Revenue and Forecast, by Indication
13.4.10.5. Market Revenue and Forecast, by End-User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Indication
13.4.11.2. Market Revenue and Forecast, by Product & Service
13.4.11.3. Market Revenue and Forecast, by Technology
13.4.11.4. Market Revenue and Forecast, by Indication
13.4.11.5. Market Revenue and Forecast, by End-User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Indication
13.5.2. Market Revenue and Forecast, by Product & Service
13.5.3. Market Revenue and Forecast, by Technology
13.5.4. Market Revenue and Forecast, by Indication
13.5.5. Market Revenue and Forecast, by End-User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Indication
13.5.6.2. Market Revenue and Forecast, by Product & Service
13.5.6.3. Market Revenue and Forecast, by Technology
13.5.6.4. Market Revenue and Forecast, by Indication
13.5.7. Market Revenue and Forecast, by End-User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Indication
13.5.8.2. Market Revenue and Forecast, by Product & Service
13.5.8.3. Market Revenue and Forecast, by Technology
13.5.8.4. Market Revenue and Forecast, by Indication
13.5.8.5. Market Revenue and Forecast, by End-User
14.1. F. Hoffmann-La Roche Ltd. (Switzerland)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies, Inc. (US)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Qiagen N.V. (Germany)
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Thermo Fisher Scientific, Inc. (US)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Abbott Laboratories, Inc. (US)
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
